EverGlade Consulting in the Media

EverGlade Consulting, a national consulting firm, has helped GeoVax Labs, Inc successfully secure up to $45 million in funding to advance the development of GEO-CM04S1, GeoVax’s dual-antigen next-generation COVID-19 vaccine through the Rapid Response Portfolio Vehicle (RRPV) consortium funded by the Biomedical Advanced Research and Development Authority (“BARDA”).

The Advanced Research Projects Agency for Health (ARPA-H) has announced a new funding opportunity through its Mission Office-specific Innovative Solution Openings (ISO). The funding opportunity aims to accelerate innovation and breakthroughs in health research by providing targeted support to projects aligned with ARPA-H’s mission areas.

The Advanced Research Projects Agency for Health (ARPA-H) has officially opened the call for Solution Summaries for its Advanced Analysis for Precision cancer Therapy (ADAPT) initiative. This initiative marks a pivotal step towards the development of personalized, innovative cancer treatments that promise to significantly enhance patient outcomes. Interested parties are encouraged to submit their Solution Summaries by the deadline of March 29, 2024, 10 AM ET.

The Advanced Research Projects Agency for Health (ARPA-H) announced the launch of the Sprint for Women’s Health initiative aimed at revolutionizing women’s health. The Sprint for Women’s Health new request for solutions (RFS) seeks proposals from innovators, researchers, and entrepreneurs to address critical challenges and disparities in women’s health.

The U.S. government, through CHIPS for America, has announced a groundbreaking funding opportunity aimed at bolstering domestic research and development (R&D) in advanced semiconductor packaging materials and substrates. 

The Advanced Research Projects Agency for Health (“ARPA-H”) recently announced a shift in how the agency will fund health-related technology research and development. ARPA-H will transition to Mission Office-Specific Innovation Solutions Openings (ISOs) to allow funding under cooperative agreements and “other transactions”. 

Government funding plays a crucial role in advancing biotech innovation by supporting collaborations between public agencies and private entities. Understanding how research grants works in biomedicine and the strategies for securing it is key for biotech companies to drive innovation and contribute to healthcare improvements.

Featured on Media Coverage. Government funding plays a crucial role in advancing biotech innovation by supporting collaborations between public agencies and private entities. Understanding how research grants works in biomedicine and the strategies for securing it is key for biotech companies to drive innovation and contribute to healthcare improvements.

EverGlade Consulting is proud to herald a renewed commitment to diversity, equity, and inclusion. We are thrilled to share our continued recognition as a Certified LGBT Business Enterprise® by the National LGBT Chamber of Commerce (NGLCC) under their Supplier Diversity Initiative.

The Rapid Response Partnership Vehicle (RRPV) Consortium is a joint initiative with the Biomedical Research and Development Authority (BARDA) to promote research and development in response to pandemics or public health emergencies. 

The Advanced Research Projects Agency for Health (ARPA-H) is transforming U.S. health research and development with innovative, high-risk, high-reward projects. Its Master Announcement Instructions (MAI) introduce a tiered proposal submission process tailored to encourage participation from both new and non-traditional applicants.

In a significant move to fortify the United States’ technological infrastructure and competitiveness, the Biden-Harris administration has announced a new Notice of Funding Opportunity (NOFO) under the Creating Helpful Incentives to Produce Semiconductors (CHIPS) for America Act.